8Carbohydrate metabolism in cardiovascular disease

https://doi.org/10.1016/S0300-595X(76)80047-3Get rights and content

Summary

Carbohydrate metabolism is temporarily disturbed in acute myocardial infarction. The degree of hyperglycaemia and failure of response of insulin appears to be related to the severity of the infarction. The underlying hormonal changes probably include increased secretion of catecholamines and of glucagon. Circulating free fatty acids (FFA) are generally increased by the same metabolic and hormonal factors which promote glucose intolerance.

In the zone of developing infarction in the heart, there is a complexmetabolic situation with glucose metabolism both being accelerated and inhibited by different factors. Continued uptake of FFA is associated with intracellular accumulation of activated long-chain FFA, acyl CoA, which tends to inhibit mitochondrial metabolism. The metabolism of glucose is thought to be beneficial and that of FFA detrimental to the infarcting tissue. Thus the glucose intolerance and the high circulating FFA occurring as part of the general metabolic response to myocardial infarction, are thought to be harmful to the ischaemic tissue. Increased provision of glucose by dichloroacetate, and inhibition of FFA metabolism by nicotinic acid analogues decrease the extent of experimental infarction, while glucose-insulin-potassium and propranolol act both by increasing glucose uptake and decreasing that of FFA.

Glucose intolerance is also common in peripheral vascular disease. The reasons for this are obscure. However, the alterations in circulating insulin concentration which accompany this intolerance may be involved in , the development of arterial lesions either directly through an effect on arterial wall synthesis or indirectly through an effect on circulating lipid levels. Defects may also be found in arterial wall mucopolysaccharide or sorbitol metabolism. The role of sex hormones and catecholamines remains speculative. At present the most cogent view is that in peripheral vascular disease a multi-hormonal disorder exists which may be contributing to the development of arteriosclerosis.

References (131)

  • GuptaD.K. et al.

    Increased plasmafree-fatty-acid concentrations and their significance in patients with acute myocardial infarction

    Lancet

    (1969)
  • HenryR.W. et al.

    Secretin: a new role for an old hormone

    Lancet

    (1975)
  • HolmJ. et al.

    Glucose tolerance, plasma insulin, and lipids in intermittent claudication with reference to muscle metabolism

    Metabolism

    (1973)
  • HorrobinD.F. et al.

    Prolactin and myocardial infarction (L)

    Lancet

    (1973)
  • JacksonW.P.U. et al.

    Insulin excess as the initial lesion in diabetes

    Lancet

    (1972)
  • KeenH. et al.

    Macroangiopathy - its prevalence in asymptomatic diabetes

  • KingsburyK.J.

    The relation between glucose tolerance and atherosclerotic vascular disease

    Lancet

    (1966)
  • KupkeI.R.

    Biosynthesis of lipids in perfused dog aorta and coronary artery. I. Incorporation of (2-14C) acetate into the lipids of three aortic layers and of the coronary artery in normal and hyperlipemic dogs

    Journal of Molecular and Cellular Cardiology

    (1972)
  • KurienV.A. et al.

    A metabolic cause for arrhythmias during acute myocardial hypoxia

    Lancet

    (1970)
  • MacKenzieG.J. et al.

    Circulatory and respiratory studies in myocardial infarction and cardiogenic shock

    Lancet

    (1964)
  • MadisonL.L. et al.

    Effect of plasma free fatty acids on plasma glucagon and serum insulin concentrations

    Metabolism

    (1968)
  • MahlerR.

    Effect of insulin on lipid metabolism of human arteries

  • NewmanH.A.I. et al.

    Cholesterol ester formation in aortas of cholesterol-fed rabbits

    Journal of Atherosclerosis Research

    (1968)
  • OpieL.H.

    Lipid metabolism of the heart and arteries in relation to ischaemic heart disease

    Lancet

    (1973)
  • OpieL.H.

    Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size

    American Journal of Cardiology

    (1975)
  • PatelskiJ. et al.

    Modification of enzyme activities in experimental atherosclerosis in the rabbit

    Atherosclerosis

    (1970)
  • RandleP.J. et al.

    The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbance of diabetes mellitus

    Lancet

    (1963)
  • ReidH.L. et al.

    Impaired red cell deformability in peripheral vascular disease

    Lancet

    (1976)
  • RosenmanR.H. et al.

    Neurogenic factors in pathogenesis of coronary heart disease

    The Medical Clinics of North America

    (1974)
  • AdamsC.W.M.

    Tissue changes and lipid entry in developing atheroma

  • AlbertiK.G.M.M. et al.

    The biochemistry of the complications of diabetes mellitus

  • AllisonS.P. et al.

    Intravenous glucose tolerance, insulin, glucose and free fatty acid levels after myocardial infarction

    British Medical Journal

    (1969)
  • BarrettA.M. et al.

    Catecholamines and the cardiovascular system

  • BingR.J.

    Reparative processes in heart muscle following myocardial infarction

    Cardiology

    (1971)
  • BloomS.R.

    R.D.

    Lawrence Lecture to the British Diabetic Association, Leeds

    (1976)
  • BremerJ.

    Regulation of fatty acid utilization

    Circulation Research

    (1976)
  • BrosnanM.E. et al.

    Effect of pancreatectomy, with and without hypophysectomy, and of insulin treatment on the composition of canine aorta

    Diabetes

    (1973)
  • ChenevalJ-P. et al.

    Heart cells in culture. Metabolism, action potential, and transmembrane ionic movements

    Journal de Physiologie

    (1972)
  • ChristensenN.J.

    Intravenous insulin causing loss of intravascular water and albumin and increased adrenergic activity in diabetics

  • CrespinS.R. et al.

    Stimulation of insulin secretion by infusion of free fatty acids

    Journal of Clinical Investigation

    (1969)
  • CruickshankN.

    Coronary thrombosis and myocardial infarction

    British Medical Journal

    (1931)
  • DateyK.K. et al.

    Hyperglycemia after acute myocardial infarction

    New England Journal of Medicine

    (1967)
  • de LeirisJ. et al.

    Effects of free fatty acid and glucose on enzyme release in experimental myocardial infarction

    Nature

    (1975)
  • DintenfassL.

    The theology of blood in vascular disease

    Journal of the Royal College of Physicians

    (1971)
  • EckerströmS.

    Clinical and prognostic aspects of acute coronary occlusion

    Acta Medica Scandinavica

    (1951)
  • EfendicS. et al.

    Trauma: hormonal factors with special reference to diabetes mellitus

    Acta Anaesthetica Scandinavica

    (1974)
  • EllenbergM. et al.

    Hyperglycemia in coronary thrombosis

    Diabetes

    (1952)
  • EpsteinF.H.

    Glucose intolerance and cardiovascular disease

    Triangle

    (1973)
  • FeligP.
  • GerichJ.E. et al.

    Prevention of human diabetic ketoacidosis by somatostatin: role of glucagon

    New England Journal of Medicine

    (1975)
  • Cited by (0)

    View full text